Pioglitazone and Prostate Cancer Risk in Taiwanese Male Patients with Type 2 Diabetes: A Retrospective Cohort Study

CHIN-HSIAO TSENG2022-06-242022-06-242022-03-022287-4208https://scholars.lib.ntu.edu.tw/handle/123456789/613315This study investigated prostate cancer risk associated with pioglitazone use.enNational Health Insurance; Pioglitazone; Prostate cancer; Taiwan[SDGs]SDG3Pioglitazone and Prostate Cancer Risk in Taiwanese Male Patients with Type 2 Diabetes: A Retrospective Cohort Studyjournal article10.5534/wjmh.210157352745062-s2.0-85127511989WOS:000766646400001https://scholars.lib.ntu.edu.tw/handle/123456789/604381